Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|March 9, 2022
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid TumorsPashtoon M Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Kohei Shitara, Florian Lordick, et al.
JCO Global Oncology|January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy DevelopmentDenis Horgan, Marcel Tanner, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B StudySusanna Slater, Annette Bryant, Maria Aresu, et al.
The Oncologist|November 7, 2022
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer TherapyDavid K Lau, Maria Aresu, Timothy Planche, et al.
Pageof 13